Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncotarget. 2015 Mar 30;6(9):6722-36.

Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.

Author information

1
University of Colorado, Department of Pediatrics, Aurora, CO, USA.
2
University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, NC, USA.
3
University of Colorado, Department of Medicine, Aurora, CO, USA.
4
Children's Hospital Colorado, Department of Pathology, Aurora, CO, USA.
5
University of North Carolina, Department of Medicine, Chapel Hill, NC, USA.

Abstract

Mer and Flt3 receptor tyrosine kinases have been implicated as therapeutic targets in acute myeloid leukemia (AML). In this manuscript we describe UNC1666, a novel ATP-competitive small molecule tyrosine kinase inhibitor, which potently diminishes Mer and Flt3 phosphorylation in AML. Treatment with UNC1666 mediated biochemical and functional effects in AML cell lines expressing Mer or Flt3 internal tandem duplication (ITD), including decreased phosphorylation of Mer, Flt3 and downstream effectors Stat, Akt and Erk, induction of apoptosis in up to 98% of cells, and reduction of colony formation by greater than 90%, compared to treatment with vehicle. These effects were dose-dependent, with inhibition of downstream signaling and functional effects correlating with the degree of Mer or Flt3 kinase inhibition. Treatment of primary AML patient samples expressing Mer and/or Flt3-ITD with UNC1666 also inhibited Mer and Flt3 intracellular signaling, induced apoptosis, and inhibited colony formation. In summary, UNC1666 is a novel potent small molecule tyrosine kinase inhibitor that decreases oncogenic signaling and myeloblast survival, thereby validating dual Mer/Flt3 inhibition as an attractive treatment strategy for AML.

KEYWORDS:

TAM receptors; acute myeloid leukemia; tyrosine kinase inhibitor

PMID:
25762638
PMCID:
PMC4466645
DOI:
10.18632/oncotarget.3156
[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances, Grant support

Publication type

MeSH terms

Substances

Grant support

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Impact Journals, LLC Icon for PubMed Central
    Loading ...
    Support Center